Drug Price Trends for PHENAZOPYRIDINE HCL

Average Pharmacy Cost for PHENAZOPYRIDINE HCL

These are average pharmacy acquisition costs (net of discounts) from a US national survey

Drug Name	NDC	Price/Unit ($)	Unit	Date
PHENAZOPYRIDINE HCL 95 MG TAB	00536-1411-07	0.12142	EACH	2025-03-19
PHENAZOPYRIDINE HCL 95 MG TAB	00536-1411-07	0.11911	EACH	2025-02-19
PHENAZOPYRIDINE HCL 95 MG TAB	00536-1411-07	0.11894	EACH	2025-01-22
PHENAZOPYRIDINE HCL 95 MG TAB	00536-1411-07	0.12055	EACH	2024-12-18
PHENAZOPYRIDINE HCL 95 MG TAB	00536-1411-07	0.12360	EACH	2024-11-20

Market Analysis and Price Projections for Phenazopyridine HCL

Overview of Phenazopyridine HCL

Phenazopyridine HCL, commonly known by brand names such as Pyridium and Uro-Pain, is a medication used to relieve pain, burning, and the frequent need to urinate associated with urinary tract infections, dysuria, and interstitial cystitis. Here’s a comprehensive analysis of the market and price projections for this drug.

Global Market Size and Growth

The global Phenazopyridine market was valued at approximately USD 550 million in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 4.5% from 2023 to 2028. This growth is driven by the increasing prevalence of urinary tract infections and the growing demand for effective symptomatic relief[3].

Market Drivers

• Increasing Prevalence of Urinary Tract Infections: The rising incidence of urinary tract infections is a significant driver for the Phenazopyridine market.
• Emerging Markets: Improved healthcare access and diagnostic facilities in emerging markets are contributing to the market's growth.
• Technological Advancements: AI-driven data analytics and automation in manufacturing are enhancing efficiency and reducing costs, further supporting market growth[3].

Export and Import Trends

Global Export Data

From March 2023 to February 2024, there were 74 shipments of Phenazopyridine HCL worldwide, marking a 40% growth rate compared to the preceding twelve months. India, Peru, and the United States are the top exporters, with India leading the world in Phenazopyridine HCL exports with 467 shipments. The primary importers include Peru, the United States, and Bolivia[1].

Pricing and Cost Analysis

Retail Prices

The cost for Phenazopyridine HCL varies based on the dosage and quantity. Here are some retail price points:

• 95 mg Oral Tablet: Prices range from $13.15 to $17.65 for 30 tablets, with a per-unit cost of $0.44 to $0.59[2].
• 100 mg Oral Tablet: Prices range from $13.97 for 6 tablets to $307.07 for 500 tablets, with a per-unit cost of $2.33 to $0.61[2].
• 200 mg Oral Tablet: Prices range from $16.82 for 6 tablets to $505.85 for 500 tablets, with a per-unit cost of $2.80 to $1.01[2].

Cost Without Insurance

Without insurance, Phenazopyridine HCL can cost around $6 per tablet or $37 for a two-day prescription dose of 6 tablets. However, using prescription discount cards can significantly reduce the cost to as low as $2 for a two-day supply[5].

Market Competition and Key Players

The Phenazopyridine market is competitive, with several key players:

• Yichuang Pharma
• Guorun Zhiyao
• Biotech Laboratories
• Roche
• Novell Pharmaceutical Laboratories
• Sun Pharmaceutical

These companies are implementing various strategies to maintain and expand their market share, including the adoption of advanced technologies and expansion into emerging markets[3].

Regional Market Analysis

North America

North America, particularly the United States, plays a pivotal role in the Phenazopyridine market. The region is expected to continue its significant growth driven by the high adoption of advanced technology and the presence of major industry players[3].

Europe

Europe is also anticipated to experience significant growth, with a strong CAGR during the forecast period. The region's growth is supported by the increasing demand for effective treatments for urinary tract infections[3].

Emerging Markets

Emerging markets are contributing substantially to the growth of the Phenazopyridine market due to improved healthcare access and diagnostic facilities. These markets offer significant opportunities for expansion and growth[3].

Technological Impact

AI and Automation

AI-driven data analytics and machine learning are enhancing the efficiency of drug development processes, including the identification of new therapeutic applications and optimization of production techniques. Automation in manufacturing is leading to reduced costs and increased production capabilities, further supporting market growth[3].

Market Dynamics and Challenges

Market Dynamics

The Phenazopyridine market is influenced by several dynamics, including market drivers, restraints, opportunities, and threats. The increasing prevalence of urinary tract infections and the growing demand for symptomatic relief are key drivers. However, the availability of alternative treatments and regulatory challenges can act as restraints[4].

Challenges and Opportunities

Despite the growth, the market faces challenges such as economic impacts, regulatory hurdles, and the need for continuous innovation. Opportunities include expanding into emerging markets, adopting advanced technologies, and developing new therapeutic applications[4].

Price Projections

Short-Term Projections

In the short term, prices for Phenazopyridine HCL are expected to remain relatively stable, influenced by the current supply and demand dynamics. However, fluctuations can occur due to stock shortages and other market variables[2].

Long-Term Projections

Long-term price projections indicate a potential decrease in costs due to increased efficiency in manufacturing and the adoption of automation. The CAGR of 4.5% from 2023 to 2028 suggests a steady market growth, which could lead to more competitive pricing as the market expands[3].

Key Takeaways

• Market Growth: The global Phenazopyridine market is projected to grow at a CAGR of 4.5% from 2023 to 2028.
• Pricing: Retail prices vary based on dosage and quantity, with significant discounts available through prescription cards.
• Key Players: Major pharmaceutical companies are driving the market through technological advancements and strategic expansions.
• Regional Growth: North America and Europe are key regions, with emerging markets contributing significantly to growth.
• Technological Impact: AI and automation are enhancing efficiency and reducing costs.

FAQs

What is the current market size of the Phenazopyridine market?

The global Phenazopyridine market was valued at approximately USD 550 million in 2022[3].

Who are the top exporters of Phenazopyridine HCL?

India, Peru, and the United States are the top exporters of Phenazopyridine HCL[1].

How much does Phenazopyridine HCL cost without insurance?

Phenazopyridine HCL can cost around $6 per tablet or $37 for a two-day prescription dose of 6 tablets without insurance[5].

What are the key drivers of the Phenazopyridine market?

The increasing prevalence of urinary tract infections and the growing demand for effective symptomatic relief are key drivers of the market[3].

How is technology impacting the Phenazopyridine market?

AI-driven data analytics and automation in manufacturing are enhancing efficiency, reducing costs, and increasing production capabilities[3].

Which regions are expected to see significant growth in the Phenazopyridine market?

North America, particularly the United States, and Europe are expected to see significant growth, along with emerging markets[3].

Sources

1. Volza: Phenazopyridine Hydrochloride Exports from World - Volza
2. Drugs.com: Phenazopyridine Prices, Coupons, Copay Cards & Patient Assistance
3. Verified Market Reports: Phenazopyridine Market Impact of AI and Automation
4. Prof-Research: Phenazopyridine hydrochloride Market Size, Share, Trend and ...
5. SingleCare: How much is phenazopyridine HCl (Pyridium) without insurance?